IUC26700-80

Abstract Code: IUC26700-80   Real world analysis of first line systemic anti-cancer treatment for metastatic Renal cell carcinoma E. Woods 1, S. Growcott 1, A. Gee 1 (1) Royal United Hospital, Bath – United Kingdom   Objective: Landmark clinical trials...

IUC26699-97

Abstract Code: IUC26699-97   Who Gets Left Out? The Real-World Eligibility Gap in Landmark Metastatic Renal Cell Carcinoma Trials Zeb 1 (1) university Hospital Birmingham – United Kingdom   Who Gets Left Out? The Real-World Eligibility Gap in Landmark...

IUC26697-95

Abstract Code: IUC26697-95 First Line Tyrosine Kinase Inhibitors (TKIs) in metastatic Renal Cell Cancer (mRCC)- A regional cancer Centre experience. R. Gul 1, O. Oghenevwede 2, E. Fetherston 1, O. Shahin 1, K. Kumar 2 (1) Freeman Hospital, Newcastle upon Tyne –...

IUC26695-93

Abstract Code: IUC26695-93   Real-world Outcomes of First-line Immune Checkpoint Inhibitor–Tyrosine Kinase Inhibitor Combination Therapy in Metastatic Renal Cell Carcinoma: A Regional Cancer Centre Experience R. Gul 1, E. Fetherston 1, O. Oghenevwede 2, O. Shahin...

IUC26694-92

Abstract Code: IUC26694-92   Stereotactic Body Radiotherapy and Immunotherapy for Metastatic Renal Cell Carcinoma Croatian Uro-Oncology Network Experience H. Brcic 1, J. Murgic 1, K. Brcic 2, M. Lekic 3, I. Tomaskovic 4, M. Jazvic 1, D. Schwarz 3, M. Penc 5, T....

IUC26693-91

Abstract Code: IUC26693-91   CHOLESTEROL HOMEOSTASIS AND IMMUNE-INFLAMMATORY PROFILES IN PATIENTS WITH mRCC RECEIVING IMMUNOTHERAPY P. Tuttobene 1, M. Maffezzoli 2, G. Leali 1, M. Pluchino 3, E. Favari 4, G. Mazzaschi 3, F. Pecci 3, M. Tiseo 3, M. Di Maio 5, S....
error: Content is protected !!